- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01596985
Ovarian Endometrioma Ablation Using Plasma Energy Versus Cystectomy
Prospective, Monocentric Study Comparing Cystectomy to PlasmaJet Ablation in the Surgical Management of Ovarian Endometriomas
Objective: To compare loss of ovarian parenchyma following ovarian endometrioma ablation using the PlasmaJet system versus cystectomy, using postoperative examination by 3D ultrasound.
Design: Prospective comparative study. Setting: Two experienced surgeons practicing in two University tertiary referral centers.
Patients: Fifty women with no previous history of ovarian surgery managed for unilateral ovarian endometrioma > 30 mm in diameter.
Interventions: Endometrioma ablation by plasma energy using the PlasmaJet system and ovarian tissue sparing cystectomy.
Main Outcome Measures: 3D ultrasound assessment of postoperative reduction in ovarian volume and antral follicle count (AFC) .
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The management of ovarian endometriomas in women wishing to conceive remains challenging. Recent data suggest that excising endometriomas by ovarian tissue sparing cystectomy does not avoid inadvertent removal of ovarian parenchyma surrounding the cyst, particularly in enlarged cysts. Although several authors question whether the ovarian parenchyma immediately surrounding the cyst may still be functional, there is little doubt that postoperative fertility could be significantly impaired by loss of ovarian cortex and provokes the question as to whether pregnancy should be initiated before performing a cystectomy, whenever this scenario is possible. However ovarian surgery cannot always be delayed to the postpartum period, numerous women require endometrioma management while not seeking an immediate pregnancy and still wish to conserve their procreative capabilities.
After a period of some years during which cystectomy appeared to be the best surgical technique in the treatment of ovarian endometriomas in women wishing to become pregnant, recent data have suggested that ablation of the inner layer of the endometrioma may be a valuable alternative technique, as long as the energy employed avoids thermal diffusion to surrounding ovarian tissue. The Department of Gynecology at the University Hospital in Rouen, France have introduced ablation by plasma energy using the PlasmaJet system (Plasma Surgical Ltd, Abingdon, UK) and have already been able to report encouraging results based on non comparative pilot studies and on retrospective "before and after" comparative study.
The aim of the study is to prospectively compare loss of ovarian parenchyma and decrease in antral follicle count (AFC) following ovarian endometrioma ablation using plasma energy versus cystectomy, when performed by only two expert surgeons. Postoperative examination is carried out by 3D ultrasound.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Contact
- Name: Horace Roman, MD PhD
- Phone Number: 0033232888643
- Email: Horace.Roman@gmail.com
Study Locations
-
-
Auvergne
-
Clermont Ferrand, Auvergne, France, 63033
- Recruiting
- University Hospital
-
Contact:
- Michel Canis, MD PhD
- Phone Number: +33473750750
- Email: mcanis@chu-clermontferrand.fr
-
Sub-Investigator:
- Jean-Luc Pouly, MD
-
Sub-Investigator:
- Nicolas Bourdel, MD
-
-
Seine-Maritime
-
Rouen, Seine-Maritime, France, 76031
- Recruiting
- University Hospital
-
Contact:
- Horace Roman, MD PhD
- Phone Number: +33232888643
- Email: horace.roman@gmail.com
-
Principal Investigator:
- Horace Roman, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 18 and 45 years;
- Surgery required by pelvic pain or infertility related to endometriosis;
- Clinical and imaging data proving unilateral ovarian endometrioma which diameter exceeds 30 mm.
Exclusion Criteria:
- Previous surgery on ovaries or IVF procedures;
- Bilateral endometriomas;
- Pregnancy
- Woman not French speaker.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ablation using the PlasmaJet system
Origin of cyst invagination is identified after lysis of adhesions between ovary and adjacent broad ligament, leading to characteristic "chocolate fluid" evacuation.
Surgeon then attempts to turn cyst completely inside out via original invagination site of diameter averaging 1 to 2cm.
Ablation of cyst's inner surface is performed using the PlasmaJet system in coagulation mode set at 40, at distance averaging 5mm from tip of handpiece, and with exposure time limited to 1 to 2s on each site.
Care is taken not to leave any untreated sites and to ablate the edges of the invagination site and corresponding peritoneal implants on adjacent broad ligament.
When cyst reversion is not feasible, surgeon progressively exposes cyst interior to guide plasma beam at an angle perpendicular to the inner surface.
|
Ablation of the inner surface of the cyst is then performed using the PlasmaJet system in coagulation mode set at 40, at a distance averaging 5 mm from the tip of the handpiece, and with an exposure time limited to 1 to 2 seconds on each site.
Care is taken not to leave any untreated sites and to ablate the edges of the invagination site and the corresponding peritoneal implants on the adjacent broad ligament.
Other Names:
|
Active Comparator: Cystectomy
Surgical excision of an ovarian endometrioma by cystectomy involves three distinct areas, each requiring a different excision procedure.
Area A from where cyst invagination originates, measures 1 cm² on average and is revealed by lysing adhesions between the ovary and the adjacent broad ligament, leading to the characteristic "chocolate fluid" evacuation.
The excision by scissors of area A allows the surgeon to identify a cleavage plane close to the cyst wall, which can be followed without significant bleeding (area B).
Should adhesions appear in the cleavage plane, they are coagulated and cut, so as not to strip the ovarian cortex.
Close to the ovarian hilus, for complete cyst removal, adhesions require coagulation using bipolar current and section by scissors (area C).
|
Surgical excision of an ovarian endometrioma by cystectomy involves three distinct areas, each requiring a different excision procedure.
Area A from where cyst invagination originates, measures 1 cm² on average and is revealed by lysing adhesions between the ovary and the adjacent broad ligament, leading to the characteristic "chocolate fluid" evacuation.
The excision by scissors of area A allows the surgeon to identify a cleavage plane close to the cyst wall, which can be followed without significant bleeding (area B).
Should adhesions appear in the cleavage plane, they are coagulated and cut, so as not to strip the ovarian cortex.
Close to the ovarian hilus, for complete cyst removal, adhesions require coagulation using bipolar current and section by scissors (area C).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Loss of ovarian volume
Time Frame: 3 months postoperatively
|
Evaluation of ovarian volumes of both the operated and the contralateral healthy ovary using a tridimensional ultrasound by vaginal route.
The volume of each ovary expressed in cm³ was estimated using the formula D1 x D2 x D3 x π / 6.
The Mann and Whitney test is performed to compare measurements made on the operated ovaries vs. those made on the contralateral ovaries.
|
3 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Decrease in ovarian antral follicles count (AFC)
Time Frame: 3 months postoperatively
|
Evaluation of antral follicle counts in both the operated and the contralateral, healthy ovary, using tridimensional ultrasound.
The Mann and Whitney test is performed to compare the decrease in AFC depending on surgical procedure.
|
3 months postoperatively
|
Antimullerian Hormone level (AMH)
Time Frame: 3 months postoperatively
|
AMH level are measured before and 3 months after the surgery to evaluate the decrease in AMH level depending on surgical technique.
|
3 months postoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Horace Roman, MD, PhD, University Hospital, Rouen, France
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.S.PJ.6.10.GYN
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ovarian Endometrioma
-
Medical University of ViennaRecruitingOvarian Endometrioma | Ovarian EndometriosisAustria
-
Shanghai First Maternity and Infant HospitalShanghai Tongji Hospital, Tongji University School of Medicine; International...RecruitingOvarian Reserve | Ovarian EndometriomaChina
-
Yonsei UniversityRecruiting
-
Hospital Clinic of BarcelonaCompleted
-
Yonsei UniversityUnknownUnilateral Ovarian EndometriomaKorea, Republic of
-
Cairo UniversityUnknownOvarian EndometriomaEgypt
-
University of CagliariUniversity of FoggiaCompletedOvarian EndometriomaItaly
-
Shaimaa Mostafa Mohammed Refaay El shemyCompletedOvarian EndometriomaEgypt
-
Uludag UniversityUnknownOvarian Reserve, Endometrioma, PTEN-AKT-FOXO3 Gene ExpressionTurkey
-
Far Eastern Memorial HospitalRecruitingOvarian EndometriomaTaiwan
Clinical Trials on Ablation using the PlasmaJet system
-
Medtronic - MITGCompletedHIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-Grade Squamous Intraepithelial LesionsUnited States
-
AtriCure, Inc.Unknown
-
Galaxy Medical, Inc.Active, not recruitingAtrial FibrillationCanada
-
AtriCure, Inc.CompletedAtrial FibrillationUnited States
-
Rigshospitalet, DenmarkUnknown
-
University of California, San FranciscoMedtronicCompleted
-
FUSMobile Inc.RambamCompletedFacet Syndrome of Lumbar SpineIsrael
-
Barts & The London NHS TrustAtriCure, Inc.Not yet recruitingAtrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial Arrhythmia | Atrium; FibrillationUnited Kingdom
-
Antonio Berruezo, MD, PhDRecruiting
-
Insel Gruppe AG, University Hospital BernUniversity of BernActive, not recruitingParoxysmal Atrial FibrillationSwitzerland